ACELRX PHARMACEUTICALS INC (ACRXXXXX)
Institutional ownership reported to the SEC as of Q4 2022, across 17 quarters.
1
Reporting holders
$4.1K
Reported value
0.0%
Held as options
-47
Holder change
Options share is the part of reported value carried in derivative lines rather than shares. A high figure means institutions are expressing a view on this security without owning much of it.
Holders
| Filer | Value | Shares | Their book | Held | Change |
|---|---|---|---|---|---|
| CoreCap Advisors, LLC | $4.1K | 1,800 | 0.00% | 5q | -95.0%-$77.3K |
Quarter by quarter
Coverage begins with the quarter ending 2018-12-31. Earlier filings exist only as occasional late amendments, too sparse to describe a market, so they are not shown.
| Quarter | Holders | Value | Shares | New | Added | Trimmed | Options |
|---|---|---|---|---|---|---|---|
| Q4 2022 | 1 | $4.1K | 1,800 | 0 | 0 | 1 | 0.0% |
| Q3 2022 | 48 | $3.8M | 18,243,726 | 7 | 12 | 7 | 0.0% |
| Q2 2022 | 53 | $4.2M | 17,100,643 | 12 | 11 | 6 | 0.0% |
| Q1 2022 | 47 | $5.7M | 19,852,368 | 5 | 8 | 9 | 0.5% |
| Q4 2021 | 58 | $17.0M | 30,054,909 | 8 | 13 | 9 | 0.7% |
| Q3 2021 | 58 | $21.0M | 20,070,372 | 8 | 8 | 23 | 2.6% |
| Q2 2021 | 71 | $35.1M | 25,194,811 | 16 | 11 | 27 | 1.0% |
| Q1 2021 | 82 | $62.4M | 36,216,746 | 18 | 27 | 18 | 1.3% |
| Q4 2020 | 76 | $30.9M | 24,328,961 | 9 | 26 | 16 | 2.1% |
| Q3 2020 | 72 | $32.4M | 22,674,020 | 6 | 25 | 21 | 0.8% |
| Q2 2020 | 75 | $21.9M | 18,020,741 | 14 | 18 | 23 | 0.2% |
| Q1 2020 | 68 | $22.7M | 19,132,725 | 7 | 19 | 17 | 0.5% |
| Q4 2019 | 78 | $43.6M | 19,861,103 | 12 | 17 | 25 | 3.8% |
| Q3 2019 | 67 | $42.5M | 18,452,177 | 6 | 21 | 17 | 4.5% |
| Q2 2019 | 70 | $48.7M | 17,470,682 | 23 | 21 | 12 | 9.3% |
| Q1 2019 | 69 | $45.8M | 12,253,929 | 14 | 16 | 19 | 7.0% |
| Q4 2018 | 65 | $38.8M | 15,143,398 | 5 | 1 | 0 | 9.8% |